Accretion Pharma Board Approves Key Proposals for Shareholder Vote
Accretion Pharmaceuticals Ltd 路 Others (Uncategorized) 路 01 Sept 2026, 7:15 pm
Accretion Pharma Board Approves Key Proposals for Shareholder Vote Accretion Pharmaceuticals' Board, on 1st Sep'26, approved key proposals subject to shareholder approval via postal ballot. These include altering the company's Object Clause in its Memorandum of Association to expand business activities. The Board also seeks to increase borrowing limits, enhance limits for creating security on company assets, and approve loans, guarantees, and investments exceeding prescribed thresholds under the Companies Act, 2013. These moves signal potential strategic expansion and future capital-raising activities, pending shareholder and regulatory consent.
Original exchange filing (PDF)
More announcements from Accretion Pharmaceuticals Ltd
- Accretion Pharmaceuticals Limited has informed the Exchange about General Updates 路 16 Nov 2026
- Accretion Pharmaceuticals Limited has informed the Exchange about Investor Presentation 路 03 Nov 2026
- Accretion Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 02 Nov 2026
- Accretion Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 31, 2026, titled "Company Reports 25.83% Revenue Growth and 72.63% PAT Growth in H1 FY27 and Strong EBITDA Growth of 72.28%; EBITDA Margin Improves to 22.48%". 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has submitted to the Exchange, the unaudited financial results for the half year ended September 30, 2026. 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 31-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 31 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has submitted the Exchange a copy of Srutinizers report. 路 12 Oct 2026
